Cariprazine is best described as which of the following?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Master HIV/AIDS Antiretroviral Therapy Test with comprehensive flashcards and multiple-choice questions. Each question provides detailed explanations to enhance your knowledge. Prepare effectively and excel in your exam!

Multiple Choice

Cariprazine is best described as which of the following?

Explanation:
This question tests how cariprazine interacts with receptors. Cariprazine acts as a partial agonist at dopamine D2 and D3 receptors, with a notable affinity for D3, and it also has partial agonist activity at 5-HT1A receptors. That means it modulates dopamine signaling rather than completely blocking it, and it engages serotonergic receptors as well. So a description that cites partial agonism at D2 and D3 and activity at 5-HT1A best matches its pharmacology. It is not a full antagonist at D2, and it does have receptor activity beyond D2, so the other statements don’t fit.

This question tests how cariprazine interacts with receptors. Cariprazine acts as a partial agonist at dopamine D2 and D3 receptors, with a notable affinity for D3, and it also has partial agonist activity at 5-HT1A receptors. That means it modulates dopamine signaling rather than completely blocking it, and it engages serotonergic receptors as well. So a description that cites partial agonism at D2 and D3 and activity at 5-HT1A best matches its pharmacology. It is not a full antagonist at D2, and it does have receptor activity beyond D2, so the other statements don’t fit.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy